Rapid nanobody-based imaging of mesothelin expressing malignancies compatible with blocking therapeutic antibodies.

Benloucif A, Meyer D, Balasse L, Goubard A, Danner L, Bouhlel A, Castellano R, Guillet B, Chames P, Kerfelec B

DOI: 10.3389/fimmu.2023.1200652
Published: 2023
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2023.1200652,
  title = {Rapid nanobody-based imaging of mesothelin expressing malignancies compatible with blocking therapeutic antibodies.},
  author = {Benloucif A and Meyer D and Balasse L and Goubard A and Danner L and Bouhlel A and Castellano R and Guillet B and Chames P and Kerfelec B},
  year = {2023},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2023.1200652},
  url = {https://doi.org/10.3389/fimmu.2023.1200652}
}

RIS

TY  - JOUR
TI  - Rapid nanobody-based imaging of mesothelin expressing malignancies compatible with blocking therapeutic antibodies.
AU  - Benloucif A
AU  - Meyer D
AU  - Balasse L
AU  - Goubard A
AU  - Danner L
AU  - Bouhlel A
AU  - Castellano R
AU  - Guillet B
AU  - Chames P
AU  - Kerfelec B
PY  - 2023
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2023.1200652
UR  - https://doi.org/10.3389/fimmu.2023.1200652
ER  -

APA

A, B., D, M., L, B., A, G., L, D., A, B., R, C., B, G., P, C., & B, K. (2023). Rapid nanobody-based imaging of mesothelin expressing malignancies compatible with blocking therapeutic antibodies.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2023.1200652

Source records

pubmed · retrieved 2026-09-26T08:58:52.992Z